Psyence Biomedical PBM Cash Flow Statement (2023-2025)

NASDAQ PBM
$3.93 -0.17 (-4.15%)
At close: Aug 20, 2026 · 4:00 PM EDT
Cash Flow Statement Mar2023 Sep2023 Sep2024 Sep2025
Operating Activities
Net Income (Quarter) -3.21M-0.31M0.14M-1.50M
Depreciation and Depletion (Quarter) 0.00M0.00M
Gains from Investment Securities (Quarter) 0.00M-0.06M
Cash from Operations (Quarter) -1.59M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF) (Quarter) 0.00M0.00M
Investing Activities
Acquisitions (Quarter) 1.75M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt Issuances (Quarter) 0.71M
Misc.
Exchange Rate Effect (Quarter) -0.08M
Change in Cash (Quarter) -0.42M
Free Cash Flow (Quarter) -1.59M
Net Cash Flow (Quarter) -1.59M